HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Emerging biomarker technologies are a significant breakthrough in cancer research, offering new possibilities for the detection, monitoring, and treatment of cancer. Biomarkers, which are biological indicators found in blood, urine, or tissue samples, can provide early warning signs of cancer, often before symptoms appear. Advances in genomics, proteomics, and other high-throughput technologies have accelerated the identification of novel biomarkers that can predict disease progression, monitor treatment responses, and detect relapse. These biomarkers also help in the development of targeted therapies, allowing clinicians to tailor treatments to the specific genetic makeup of a patient’s tumor. As biomarker discovery continues to evolve, it holds the potential to transform early cancer detection and personalized medicine.
